Moleculin Biotech's Debt Round

Moleculin Biotech raised a round of funding on October 16, 2014.

Moleculin Biotech is a preclinical and clinical-stage pharmaceutical company focused on the development of anti-cancer drug candidates, many of which are based on discoveries made at M.D. Anderson Can…

Articles about Moleculin Biotech's Debt Round: